ATE114114T1 - Verwendung von benzimidazol-derivaten als antibakterielle mittel. - Google Patents

Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Info

Publication number: ATE114114T1
Authority: AT; Austria
Prior art keywords: antibacterial agents; benzimidazole derivatives; stands; hydrogen; campylobacter
Prior art date: 1989-02-10

Application number

AT90301256T

Other languages

English (en)

Inventor

Tomoyuki Iwahi

Hiroshi Satoh

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-10

Filing date

1990-02-06

Publication date

1994-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE114114(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-02-06 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1994-12-15 Application granted granted Critical

1994-12-15 Publication of ATE114114T1 publication Critical patent/ATE114114T1/de

Links

239000003242 anti bacterial agent Substances 0.000 title 1
229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
150000001556 benzimidazoles Chemical class 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
241000589876 Campylobacter Species 0.000 abstract 1
208000035473 Communicable disease Diseases 0.000 abstract 1
241000590002 Helicobacter pylori Species 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
230000000844 anti-bacterial effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Plural Heterocyclic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Peptides Or Proteins (AREA)

AT90301256T 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel. ATE114114T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP3237489		1989-02-10
JP23923389		1989-09-15

Publications (1)

Publication Number	Publication Date
ATE114114T1 true ATE114114T1 (de)	1994-12-15

Family

ID=26370930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90301256T ATE114114T1 (de)	1989-02-10	1990-02-06	Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Country Status (10)

Country	Link
US (1)	US5013743A (de)
EP (1)	EP0382489B1 (de)
AT (1)	ATE114114T1 (de)
CA (1)	CA2009741C (de)
DE (1)	DE69014141T2 (de)
DK (1)	DK0382489T3 (de)
ES (1)	ES2066120T3 (de)
FI (2)	FI100168B (de)
GR (1)	GR3014973T3 (de)
NO (1)	NO900639L (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5338723A (en) *	1989-10-13	1994-08-16	Merck & Co., Inc.	Fibrinogen receptor antagonists
WO1992004898A1 (de) *	1990-09-14	1992-04-02	Byk Gulden Lomberg Chemische Fabrik Gmbh	Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachten erkrankungen
TW209174B (de) *	1991-04-19	1993-07-11	Takeda Pharm Industry Co Ltd
TW276996B (de) *	1992-04-24	1996-06-01	Astra Ab
US5504082A (en) *	1992-06-01	1996-04-02	Yoshitomi Pharmaceutical Industries, Ltd.	Pyridine compound and pharmaceutical compostions
KR950702416A (ko) *	1992-07-08	1995-07-29	제임스 클리프튼 보올딩	돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸(Benzimidazoles for alloviating stomach ulcers in swine)
DK0652751T3 (da) *	1992-07-28	1996-11-18	Astra Ab	Injektionspræparat og injektions-kit indeholdende omeprazol og dens analoger
DE69302646T2 (de) *	1992-08-21	1996-10-31	Eisai Co Ltd	Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon
AU5699594A (en) *	1992-12-10	1994-07-04	Byk Gulden Lomberg Chemische Fabrik Gmbh	Use of alkylthiopyridines for controlling helicobacter bacteria
JPH06298611A (ja) *	1993-04-16	1994-10-25	Nippon Chemiphar Co Ltd	抗菌剤
SK280159B6 (sk) *	1993-06-29	1999-09-10	Byk Gulden Lomberg Chemische Fabrik Gmbh	Substituované aryltioalkyltiopyridíny, spôsob ich
US6489346B1 (en) *	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US8071128B2 (en)	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6861448B2 (en) *	1998-01-14	2005-03-01	Virtual Drug Development, Inc.	NAD synthetase inhibitors and uses thereof
CA2317439A1 (en)	1998-01-14	1999-07-22	Wayne J. Brouillette	Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
FI104384B (fi)	1998-06-05	2000-01-14	Valmet Corp	Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
EP1310252A4 (de) *	2000-08-18	2009-06-10	Takeda Pharmaceutical	Injektionen
CN1243749C (zh) *	2001-09-18	2006-03-01	泽里新药工业株式会社	苯并咪唑衍生物
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
WO2003063840A2 (en) *	2002-01-25	2003-08-07	Santarus, Inc.	Transmucosal delivery of proton pump inhibitors
US8367111B2 (en) *	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
US20050220870A1 (en) *	2003-02-20	2005-10-06	Bonnie Hepburn	Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004073654A2 (en) *	2003-02-20	2004-09-02	Santarus, Inc.	A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
CA2531564C (en) *	2003-07-18	2016-01-19	Santarus, Inc.	Pharmaceutical composition for inhibiting acid secretion
MXPA06000524A (es) *	2003-07-18	2006-08-11	Santarus Inc	Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
US8993599B2 (en) *	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) *	2003-11-05	2007-12-20	Warren Hall	Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005076987A2 (en) *	2004-02-10	2005-08-25	Santarus, Inc.	Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
EP1742630A4 (de) *	2004-04-16	2010-01-20	Santarus Inc	Kombination aus protonenpumpenhemmer, puffermittel und prokinetischem wirkstoff
US8906940B2 (en) *	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) *	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) *	2004-07-29	2006-02-02	Pawan Seth	Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) *	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
NZ589750A (en)	2004-10-21	2012-07-27	Aptalis Pharmatech Inc	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) *	2004-11-12	2006-05-18	Eurand Pharmaceuticals Limited	Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
EP1934201A1 (de) *	2005-10-06	2008-06-25	Auspex Pharmaceuticals Inc.	Deuterierte hemmer von gastrischer h+, k+-atpase mit verstärkten therapeutischen eigenschaften
DK2003130T3 (da) *	2006-03-10	2011-12-12	Arigen Pharmaceuticals Inc	Nyt pyridinderivat med anti-helicobacter pylori-aktivitet
CA2654402A1 (en) *	2006-06-01	2007-12-06	Adel Penhasi	Multiple unit pharmaceutical formulation
JP2009539866A (ja) *	2006-06-05	2009-11-19	オースペックス・ファーマシューティカルズ・インコーポレイテッド	置換エリスロマイシンアナログの調製および有用性
EP2068841B1 (de)	2006-10-05	2018-09-26	Santarus, Inc.	Neuartige formulierungen von protonenpumpenhemmern und verfahren zu ihrer verwendung
US20090092658A1 (en) *	2007-10-05	2009-04-09	Santarus, Inc.	Novel formulations of proton pump inhibitors and methods of using these formulations
CA2667682A1 (en)	2006-10-27	2008-05-15	The Curators Of The University Of Missouri	Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
BRPI1014314A2 (pt) *	2009-04-09	2019-09-24	Arigen Pharmaceuticals Inc	derivado de tiopiridina, e, composição farmacêutica.
CN102958515A (zh)	2009-12-02	2013-03-06	阿普塔利斯制药有限公司	非索非那定微胶囊及含有非索非那定微胶囊的组合物
US20110212171A1 (en) *	2010-01-08	2011-09-01	Eurand, Inc.	Taste masked topiramate composition and an orally disintegrating tablet comprising the same
US20170042806A1 (en)	2015-04-29	2017-02-16	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
JP2025532389A (ja)	2022-10-04	2025-09-29	ザビリュク，アルセニー	大動脈弁の石灰化の抑制

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6150978A (ja) *	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
JP2694361B2 (ja) *	1989-02-09	1997-12-24	アストラアクチエボラグ	抗菌剤

1990
- 1990-02-06 DK DK90301256.5T patent/DK0382489T3/da active
- 1990-02-06 AT AT90301256T patent/ATE114114T1/de active
- 1990-02-06 EP EP90301256A patent/EP0382489B1/de not_active Expired - Lifetime
- 1990-02-06 ES ES90301256T patent/ES2066120T3/es not_active Expired - Lifetime
- 1990-02-06 DE DE69014141T patent/DE69014141T2/de not_active Expired - Lifetime
- 1990-02-09 CA CA002009741A patent/CA2009741C/en not_active Expired - Lifetime
- 1990-02-09 NO NO90900639A patent/NO900639L/no unknown
- 1990-02-09 FI FI900662A patent/FI100168B/fi active IP Right Grant
- 1990-02-12 US US07/478,405 patent/US5013743A/en not_active Expired - Lifetime
1994
- 1994-02-28 FI FI940951A patent/FI104045B/fi active
1995
- 1995-02-08 GR GR940403729T patent/GR3014973T3/el unknown

Also Published As

Publication number	Publication date
DK0382489T3 (da)	1995-01-16
FI104045B1 (fi)	1999-11-15
ES2066120T3 (es)	1995-03-01
DE69014141D1 (de)	1994-12-22
CA2009741C (en)	1999-03-23
FI900662A0 (fi)	1990-02-09
FI100168B (fi)	1997-10-15
EP0382489B1 (de)	1994-11-17
GR3014973T3 (en)	1995-05-31
EP0382489A2 (de)	1990-08-16
EP0382489A3 (de)	1991-06-12
CA2009741A1 (en)	1990-08-10
FI104045B (fi)	1999-11-15
FI940951A0 (fi)	1994-02-28
NO900639L (no)	1990-08-13
FI940951L (fi)	1994-02-28
DE69014141T2 (de)	1995-05-24
NO900639D0 (no)	1990-02-09
US5013743A (en)	1991-05-07

Publication	Publication Date	Title
ATE114114T1 (de)	1994-12-15	Verwendung von benzimidazol-derivaten als antibakterielle mittel.
ATE215530T1 (de)	2002-04-15	7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
NZ228893A (en)	1990-06-26	Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
BG106390A (en)	2002-12-29	Novel spiro compounds
ATE82966T1 (de)	1992-12-15	Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
DE60204452D1 (de)	2005-07-07	Pyrazolo[1,5]pyridinderivate
ATE227277T1 (de)	2002-11-15	Isoxazoline derivate und ihre verwendung als antimikroben
PT867436E (pt)	2004-09-30	Derivados de n-aril-piperidina e sua utilizacao como ligandos do receptor 5-ht1b
NO934718D0 (no)	1993-12-20	Nye HIV protease inhibitorer
NO304833B1 (no)	1999-02-22	Nye pyrrolokarbazoler
DE69231422D1 (de)	2000-10-12	Pyridoncarbonsäurederivate
ATE159728T1 (de)	1997-11-15	Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
YU83993A (sh)	1996-10-09	Novi derivati piridon organske kiseline
ATE209633T1 (de)	2001-12-15	Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
MXPA02011234A (es)	2004-10-15	Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
ATE279191T1 (de)	2004-10-15	Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE119523T1 (de)	1995-03-15	Isochinolinderivate und ihre salze als proteasehemmer.
ATE275560T1 (de)	2004-09-15	Bemzimidazolverbindungen und medikamente die diese enthalten
DE69837628D1 (de)	2007-05-31	Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE69711506D1 (de)	2002-05-08	Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE222255T1 (de)	2002-08-15	14-substituierte marcfortine und derivate als antiparasitäre mittel
ATE141918T1 (de)	1996-09-15	Isoquinolinderivate
DK0421668T3 (da)	1995-03-20	1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr
ES2090056T3 (es)	1996-10-16	Derivados de pirroloquinolina, su utilizacion como agentes antimicrobianos y procedimientos para su preparacion.
TH15282A (th)	1995-01-17	" อนุพันธ์ควิโนโลน และแนพธิริโดนคาร์บอกซิลิแอซิด "